Commodore Capital LP Vera Therapeutics, Inc. Transaction History
Commodore Capital LP
- $1.18 Billion
- Q3 2024
A detailed history of Commodore Capital LP transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Commodore Capital LP holds 2,475,000 shares of VERA stock, worth $113 Million. This represents 9.29% of its overall portfolio holdings.
Number of Shares
2,475,000
Previous 2,475,000
-0.0%
Holding current value
$113 Million
Previous $89.5 Million
22.14%
% of portfolio
9.29%
Previous 8.03%
Shares
4 transactions
Others Institutions Holding VERA
# of Institutions
184Shares Held
55.1MCall Options Held
134KPut Options Held
156K-
Avoro Capital Advisors LLC New York, NY4.31MShares$197 Million2.87% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.94MShares$180 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$153 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$135 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$128 Million11.68% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $1.24B
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...